Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | MC4R | P32245 | 2/20 | 0.48 |
| ▸ | MC5R | P33032 | 2/20 | 0.48 |
| ▸ | MC3R | P41968 | 2/20 | 0.48 |
| ▸ | GHSR | Q92847 | 2/20 | 0.48 |
| ▸ | HTR2A | P28223 | 2/20 | 0.47 |
| ▸ | HTR2C | P28335 | 1/20 | 0.47 |
| ▸ | HTR2B | P41595 | 1/20 | 0.47 |
| ▸ | FCER2 | P06734 | 2/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
| ▸ | MMP9 | P14780 | 2/20 | 0.44 |
| ▸ | MMP8 | P22894 | 1/20 | 0.44 |
| ▸ | PPARG | P37231 | 2/20 | 0.43 |
| ▸ | PPARA | Q07869 | 2/20 | 0.43 |
| ▸ | PPARD | Q03181 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.41 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL900942 | 0.86 | ADRA2B (0.54) | HTR2AALDH1A1HPGDADRA2BADRA2C | |
| SCHEMBL18375655 | 0.82 | OPRK1 (0.47) | ACHEHTR2AHPGDOPRM1ADRA2B | |
| SCHEMBL20362254 | 0.82 | OPRK1 (0.47) | ACHEHTR2AHPGDOPRM1ADRA2B | |
| Trifluoroacetic Acid SCHEMBL13733639 | 0.80 | ADRA2B (0.47) | HTR2AALDH1A1HPGDADRA2BADRA2C | |
| SCHEMBL3006308 | 0.80 | GHSR (0.51) | ACHEMC4RMC5RMC3RGHSR | |
| SCHEMBL17161709 | 0.77 | NPC1 (0.46) | HTR2AALDH1A1HPGDADRA2BADRA2C | |
| SCHEMBL7466902 | 0.77 | NPC1 (0.46) | HTR2AALDH1A1HPGDADRA2BADRA2C | |
| SCHEMBL17559642 | 0.77 | NPC1 (0.46) | HTR2AALDH1A1HPGDADRA2BADRA2C | |
| SCHEMBL5552668 | 0.76 | MC4R (0.63) | ACHEMC4RMC5RMC3RGHSR | |
| SCHEMBL7920491 | 0.76 | MC4R (0.63) | ACHEMC4RMC5RMC3RGHSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10729677-B2 | Method for preventing and/or treating chronic traumatic encephalopathy-I | EUSTRALIS PHARMACEUTICAL LIMITED (TRADING AS PRESSURA NEURO) (AU) | 2020-08-04 | — | — | US | disclosed |
| US-20160143881-A1 | METHOD FOR PREVENTING AND/OR TREATING CHRONIC TRAUMATIC ENCEPHALOPATHY-I | EUSTRALIS PHARMACETICALS LIMITED (TRADING AS PRESSURA NEURO) (AU) | 2016-05-26 | — | — | US | disclosed |
| EP-1107744-A2 | USE OF SUBSTANCE P ANTAGONISTS FOR THE TREATMENT OF CHRONIC FATIGUE SYNDROME AND/OR FIBROMYALGIA AND USE OF NK-1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CHRONIC FATIGUE SYNDROME | Novartis AG (CH) | 2001-06-20 | — | — | EP | disclosed |
| WO-2000010545-A2 | USE OF SUBSTANCE P ANTAGONISTS FOR THE TREATMENT OF CHRONIC FATIGUE SYNDROME AND/OR FIBROMYALGIA AND USE OF NK-1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CHRONIC FATIGUE SYNDROME | NOVARTIS AG (CH) | 2000-03-02 | — | — | WO | disclosed |